Authors:
BAQI S
NABI N
HASAN SN
KHAN AJ
PASHA O
KAYANI N
HAQUE RA
HAQ IU
KHURSHID M
FISHERHOCH S
LUBY SP
MCCORMICK JB
Citation: S. Baqi et al., HIV ANTIBODY SEROPREVALENCE AND ASSOCIATED RISK-FACTORS IN SEX WORKERS, DRUG-USERS, AND PRISONERS IN SINDH, PAKISTAN, Journal of acquired immune deficiency syndromes and human retrovirology, 18(1), 1998, pp. 73-79
Authors:
MINNIS RC
HAQ IU
JACKSON PR
YEO WW
RAMSAY LE
Citation: Rc. Minnis et al., OILY FISH AND FISH-OIL SUPPLEMENTS IN THE PREVENTION OF CORONARY HEART-DISEASE, Journal of human nutrition and dietetics, 11(1), 1998, pp. 13-19
Authors:
JACKSON PR
HAQ IU
WALLIS EJ
YEO WW
RAMSAY LE
Citation: Pr. Jackson et al., THE IMPACT OF AMBULATORY BLOOD-PRESSURE ON ESTIMATION OF CARDIOVASCULAR RISK IN MILD HYPERTENSION, Journal of hypertension, 16, 1998, pp. 27105-27105
Citation: Iu. Haq et al., EFFECT OF PHOSPHATE ENRICHMENT ON THE METAL ADSORPTION PROPERTIES OF HYDROUS IRON-OXIDE, Journal of the Chemical Society of Pakistan, 20(2), 1998, pp. 99-109
Authors:
GHAHRAMANI P
HAQ IU
YEO WW
JACKSON PR
RAMSAY LE
Citation: P. Ghahramani et al., SHEFFIELD CARDIOVASCULAR RISK PROGRAM FOR TARGETING STATIN TREATMENT - SCRIPTS FOR ROUTINE USE IN GENERAL-PRACTICE, Hypertension, 32(4), 1998, pp. 2-2
Authors:
WALLIS EJ
RAMSAY LE
YEO WW
JACKSON PR
PICKIN M
HAQ IU
Citation: Ej. Wallis et al., USE OF STATINS - EVIDENCE ON EFFECTIVENESS IS STRONGER FOR STATINS THAN FOR OTHER TREATMENTS, BMJ. British medical journal, 315(7122), 1997, pp. 1618-1619
Authors:
HAQ IU
RAMSAY LE
PICKIN DM
YEO WW
JACKSON PR
PAYNE JN
Citation: Iu. Haq et al., LIPID-LOWERING FOR PREVENTION OF CORONARY HEART-DISEASE - WHAT POLICYNOW (VOL 91, PG 399, 1996), Clinical science, 91(6), 1996, pp. 773-774
Citation: Le. Ramsay et al., TARGETING LIPID-LOWERING DRUG-THERAPY FOR PRIMARY PREVENTION OF CORONARY HEART-DISEASE - AN UPDATED SHEFFIELD TABLE (VOL 348, PG 387, 1996), Lancet, 348(9036), 1996, pp. 1251-1252
Citation: Le. Ramsay et al., SHEFFIELD RISK AND TREATMENT TABLE FOR PRIMARY PREVENTION OF CORONARYHEART-DISEASE - REPLY, Lancet, 348(9033), 1996, pp. 1040-1041
Authors:
RAMSAY LE
HAQ IU
JACKSON PR
YEO WW
PICKIN DM
PAYNE JN
Citation: Le. Ramsay et al., TARGETING LIPID-LOWERING DRUG-THERAPY FOR PRIMARY PREVENTION OF CORONARY-DISEASE - AN UPDATED SHEFFIELD TABLE, Lancet, 348(9024), 1996, pp. 387-388
Citation: Iu. Haq et al., SHEFFIELD RISK AND TREATMENT TABLE FOR CHOLESTEROL-LOWERING IN PREVENTION OF CORONARY HEART-DISEASE - REPLY, Lancet, 347(8999), 1996, pp. 468-469
Citation: Iu. Haq et al., AMERICAN-COLLEGE OF PHYSICIANS GUIDELINES ON CHOLESTEROL SCREENING, Annals of internal medicine, 125(12), 1996, pp. 1010-1010
Citation: Le. Ramsay et al., MIGHT NONPHARMACOLOGICAL TREATMENT DISADVANTAGE PATIENTS WITH HYPERTENSION, Journal of human hypertension, 9(8), 1995, pp. 653-657
Citation: Iu. Haq et al., SHEFFIELD RISK AND TREATMENT TABLE FOR CHOLESTEROL-LOWERING FOR PRIMARY PREVENTION OF CORONARY HEART-DISEASE, Lancet, 346(8988), 1995, pp. 1467-1471